Remestemcel-L Fast Tracked for ARDS Due to COVID-19 By Brian Park, PharmD Publish Date December 3, 2020
Antifibrotic Therapy Gets Orphan Drug Status for Systemic Sclerosis By Brian Park, PharmD Publish Date December 1, 2020
Moderna Seeks EUA for COVID-19 Vaccine Candidate mRNA-1273 By Brian Park, PharmD Publish Date November 30, 2020
Tissue Factor Inhibitor Fast Tracked for COVID-19 By Brian Park, PharmD Publish Date November 24, 2020
Loncastuximab Tesirine Gets Priority Review for Relapsed/Refractory Diffuse Large B-Cell Lymphoma By Brian Park, PharmD Publish Date November 24, 2020
Vaccine Candidate AZD1222 Effective Against COVID-19 By Brian Park, PharmD Publish Date November 23, 2020
Antibody Cocktail for COVID-19 Gets Emergency Use Authorization By Diana Ernst, RPh Publish Date November 23, 2020
FDA Issues EUA to Baricitinib Plus Remdesivir for Hospitalized COVID-19 Patients By Brian Park, PharmD Publish Date November 20, 2020
Pfizer, BioNTech to Submit EUA Request for COVID-19 Vaccine Candidate By Brian Park, PharmD Publish Date November 20, 2020
FDA to Review AVT02, a High Concentration Biosimilar to Adalimumab By Brian Park, PharmD Publish Date November 20, 2020
Rilzabrutinib Fast Tracked for Immune Thrombocytopenia By Diana Ernst, RPh Publish Date November 19, 2020
Long-Acting Cabotegravir Gets Breakthrough Therapy Status for HIV PrEP By Diana Ernst, RPh Publish Date November 19, 2020
FDA Issues Complete Response Letter for Olanzapine/Samidorphan By Diana Ernst, RPh Publish Date November 18, 2020
Final Analysis Reveals COVID-19 Vaccine Candidate BNT162b2 95% Effective By Diana Ernst, RPh Publish Date November 18, 2020
Pegcetacoplan Gets Priority Review for Paroxysmal Nocturnal Hemoglobinuria By Brian Park, PharmD Publish Date November 17, 2020
Manufacturing Deficiencies Delay Decision on Sutimlimab for Cold Agglutinin Disease By Brian Park, PharmD Publish Date November 16, 2020
Interim Data Show COVID-19 Vaccine Candidate mRNA-1273 Near 95% Effective By Diana Ernst, RPh Publish Date November 16, 2020
